Jonathan Monson - 01 Dec 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP, Global Controller and CAO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
01 Dec 2023
Net transactions value
$0
Form type
4
Filing time
04 Dec 2023, 17:42:50 UTC
Previous filing
03 Aug 2023
Next filing
14 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Award $0 +3,562 $0.000000 3,562 01 Dec 2023 Common Stock 3,562 Direct F1, F2
transaction BSX Stock Option (Right to Buy) Award $0 +10,543 $0.000000 10,543 01 Dec 2023 Common Stock 10,543 $56.14 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in full on December 1, 2026, the third anniversary of the date of grant.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in full on December 1, 2026, the third anniversary of the date of grant.